| __timestamp | Agios Pharmaceuticals, Inc. | Wave Life Sciences Ltd. |
|---|---|---|
| Wednesday, January 1, 2014 | 19120000 | 2999000 |
| Thursday, January 1, 2015 | 35992000 | 10393000 |
| Friday, January 1, 2016 | 50714000 | 15994000 |
| Sunday, January 1, 2017 | 71124000 | 26975000 |
| Monday, January 1, 2018 | 114145000 | 39509000 |
| Tuesday, January 1, 2019 | 132034000 | 48869000 |
| Wednesday, January 1, 2020 | 149070000 | 42510000 |
| Friday, January 1, 2021 | 121445000 | 46105000 |
| Saturday, January 1, 2022 | 121673000 | 50513000 |
| Sunday, January 1, 2023 | 119903000 | 51292000 |
| Monday, January 1, 2024 | 156784000 |
Unleashing insights
In the competitive landscape of biotechnology, understanding the financial strategies of leading companies is crucial. Agios Pharmaceuticals, Inc. and Wave Life Sciences Ltd. have been pivotal players since 2014, with their Selling, General, and Administrative (SG&A) expenses offering a window into their operational priorities. Over the past decade, Agios has consistently outpaced Wave in SG&A spending, peaking in 2020 with expenses nearly 300% higher than Wave's. This trend highlights Agios's aggressive investment in administrative and sales functions, possibly reflecting a broader strategy to capture market share and drive innovation. Meanwhile, Wave's more conservative spending, which has steadily increased by approximately 70% from 2014 to 2023, suggests a focus on sustainable growth. As the biotech sector evolves, these financial patterns provide valuable insights into each company's strategic direction and market positioning.
Cost Management Insights: SG&A Expenses for Amgen Inc. and Agios Pharmaceuticals, Inc.
SG&A Efficiency Analysis: Comparing Bristol-Myers Squibb Company and Wave Life Sciences Ltd.
Comparing SG&A Expenses: Summit Therapeutics Inc. vs Wave Life Sciences Ltd. Trends and Insights
Who Optimizes SG&A Costs Better? Insmed Incorporated or Wave Life Sciences Ltd.
SG&A Efficiency Analysis: Comparing BioMarin Pharmaceutical Inc. and Agios Pharmaceuticals, Inc.
Grifols, S.A. and Agios Pharmaceuticals, Inc.: SG&A Spending Patterns Compared
Comparing SG&A Expenses: Cytokinetics, Incorporated vs Wave Life Sciences Ltd. Trends and Insights
Comparing SG&A Expenses: Vericel Corporation vs Wave Life Sciences Ltd. Trends and Insights
Breaking Down SG&A Expenses: Vericel Corporation vs Agios Pharmaceuticals, Inc.
Breaking Down SG&A Expenses: Agios Pharmaceuticals, Inc. vs Geron Corporation
Agios Pharmaceuticals, Inc. vs Novavax, Inc.: SG&A Expense Trends
Operational Costs Compared: SG&A Analysis of Agios Pharmaceuticals, Inc. and Viridian Therapeutics, Inc.